logo.png
Advanced Drug Delivery Market Size to Surpass USD 375.86 Billion by 2033
03. Mai 2024 11:05 ET | Precedence Research
Ottawa, May 03, 2024 (GLOBE NEWSWIRE) -- The global advanced drug delivery market size was valued at USD 234.84 billion in 2023 and is estimated to be worth around USD 347.99 billion by 2032, a...
InsightAce.jpg
Advanced Drug Delivery CDMO Market Latest Research Report 2023-2031 | InsightAce Analytic
23. November 2023 05:43 ET | InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Nov. 23, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Advanced Drug Delivery CDMO Market- (By Services...
AMR Logo.png
Global Paresthesia Treatment Market is Expected to Reach $7.9 Billion by 2031: Says AMR
17. November 2022 10:30 ET | Allied Market Research
Portland, OR, Nov. 17, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Paresthesia Treatment Market size was estimated at $5.4 billion in 2021 and is...
logo.png
Advanced Drug Delivery Market Size to Hit USD 201.45 Bn by 2030
13. Juli 2022 10:30 ET | Precedence Research
Ottawa, July 13, 2022 (GLOBE NEWSWIRE) -- The global advanced drug delivery market size was valued at USD 52.28 billion in 2021. The North American region is expected to dominate the market in the...
researchdrivelogo.jpg
Global Advanced Drug Delivery Market to Generate a Revenue of $94,352.5 Million by 2028, Growing at a CAGR of 10.0% From 2021-2028 [170-Pages] | Report by Research Dive
28. März 2022 09:19 ET | Research Dive
New York, USA, March 28, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global advanced drug delivery market is expected to register a revenue of $94,352.5 million...
Fior-Markets-Logo.jpg
Global Pharmaceutical Contract Manufacturing Market is Expected to Reach USD 150.82 Billion by 2025 : Fior Markets
30. September 2019 09:27 ET | Fior Markets
New Jersey, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The increasing subcontracting volume by big pharmaceutical companies, expansion in the service offering of complementary metal–oxide–semiconductor...